Notwithstanding these updates, genetic ablation of ECM1 and passive transfer of ECM1-specific antibodies in mice has yet to fully explain the characteristic pathophysiology in human diseases LiP and LS, respectively. The gene discussed is ECM1; the disease is oral cavity neoplasm.